Demcizumab (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Demcizumab" in Italian language version.

Last modified: 07:00:24, 19 August 2025 (UTC)

Ref.Un. Ref.Website

Global rank Italian rank

32nih.gov

5^th place

6^th place

11globenewswire.com

2,858^th place

3,921^st place

11fiercebiotech.com

low place

11clinicaltrials.gov

4,259^th place

3,825^th place

11oadoi.org

612^th place

14^th place

11doi.org

2^nd place

3^rd place

clinicaltrials.gov (Global: 4,259^th place; Italian: 3,825^th place)

(EN) A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer, su ClinicalTrials.gov. URL consultato il 4 maggio 2025.

doi.org (Global: 2^nd place; Italian: 3^rd place)

dx.doi.org

(EN) Smith DC, Eisenberg PD, Manikhas G, Chugh R, Gubens MA, Stagg RJ et al., A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors, in Clinical Cancer Research, vol. 20, n. 24, dicembre 2014, pp. 6295-6303, DOI:10.1158/1078-0432.CCR-14-1373, PMID 25324140.

fiercebiotech.com (Global: low place; Italian: low place)

(EN) OncoMed tanks as phase 2 cancer trial flops and Bayer flees, su Fierce BioTech. URL consultato il 4 maggio 2025.

globenewswire.com (Global: 2,858^th place; Italian: 3,921^st place)

(EN) OncoMed Pharmaceuticals Completes Enrollment of Phase 2 YOSEMITE Clinical Trial of Demcizumab in Pancreatic Cancer, su OncoMed Pharmaceuticals Inc.. URL consultato il 4 maggio 2025.

nih.gov (Global: 5^th place; Italian: 6^th place)

gsrs.ncats.nih.gov

(EN) Demcizumab, su Global Substance Registration System (GSRS). URL consultato il 4 maggio 2025.

ncbi.nlm.nih.gov

(EN) Smith DC, Eisenberg PD, Manikhas G, Chugh R, Gubens MA, Stagg RJ et al., A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors, in Clinical Cancer Research, vol. 20, n. 24, dicembre 2014, pp. 6295-6303, DOI:10.1158/1078-0432.CCR-14-1373, PMID 25324140.

oadoi.org (Global: 612^th place; Italian: 14^th place)

(EN) Smith DC, Eisenberg PD, Manikhas G, Chugh R, Gubens MA, Stagg RJ et al., A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors, in Clinical Cancer Research, vol. 20, n. 24, dicembre 2014, pp. 6295-6303, DOI:10.1158/1078-0432.CCR-14-1373, PMID 25324140.

Demcizumab (Italian Wikipedia)

clinicaltrials.gov (Global: 4,259th place; Italian: 3,825th place)

doi.org (Global: 2nd place; Italian: 3rd place)